3.565
price down icon2.88%   -0.075
 
loading
Schlusskurs vom Vortag:
$3.64
Offen:
$3.6
24-Stunden-Volumen:
30,084
Relative Volume:
0.44
Marktkapitalisierung:
$164.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-103.21M
KGV:
-0.775
EPS:
-4.6001
Netto-Cashflow:
$-26.70M
1W Leistung:
+18.23%
1M Leistung:
-7.94%
6M Leistung:
-46.84%
1J Leistung:
-60.94%
1-Tages-Spanne:
Value
$3.52
$3.68
1-Wochen-Bereich:
Value
$2.95
$3.68
52-Wochen-Spanne:
Value
$2.65
$11.00

Engene Holdings Inc Stock (ENGN) Company Profile

Name
Firmenname
Engene Holdings Inc
Name
Telefon
(514) 332-4888
Name
Adresse
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Name
Mitarbeiter
57
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ENGN's Discussions on Twitter

Vergleichen Sie ENGN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ENGN
Engene Holdings Inc
3.60 164.05M 0 -103.21M -26.70M -4.6001
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.53 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
546.98 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.49 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.21 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.90 28.51B 3.81B -644.79M -669.77M -6.24

Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-18 Eingeleitet Piper Sandler Overweight
2025-02-14 Herabstufung UBS Buy → Neutral
2024-12-23 Eingeleitet H.C. Wainwright Buy
2024-11-27 Eingeleitet Raymond James Outperform
2024-11-18 Eingeleitet JMP Securities Mkt Outperform
2024-08-28 Eingeleitet Oppenheimer Outperform
2024-04-22 Eingeleitet Wells Fargo Overweight
2024-04-15 Eingeleitet Guggenheim Buy
2024-03-28 Eingeleitet UBS Buy
2024-03-08 Eingeleitet Morgan Stanley Overweight
2024-02-20 Eingeleitet Leerink Partners Outperform
Alle ansehen

Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten

pulisher
Jun 18, 2025

enGene Holdings: Looking For An End To The 2025 Decline (Downgrade) (NASDAQ:ENGN) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 17, 2025

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) to four newly-hired employees - BioSpace

Jun 17, 2025
pulisher
Jun 17, 2025

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire

Jun 17, 2025
pulisher
Jun 16, 2025

JMP reiterates market outperform rating on enGene stock on clinical progress By Investing.com - Investing.com Nigeria

Jun 16, 2025
pulisher
Jun 16, 2025

JMP reiterates market outperform rating on enGene stock on clinical progress - Investing.com Australia

Jun 16, 2025
pulisher
Jun 16, 2025

Engene stock maintains buy rating at H.C. Wainwright on LEGEND trial - Investing.com

Jun 16, 2025
pulisher
Jun 14, 2025

enGene Holdings Inc. adopts new employee stock plan By Investing.com - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 12, 2025

enGene Holdings Reports Q2 2025 Financial Results - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Engene stock maintains Outperform rating at Raymond James on strong execution By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Engene stock maintains Outperform rating at Raymond James on strong execution - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

EnGene Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2025 - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

enGene Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace

Jun 12, 2025
pulisher
Jun 12, 2025

enGene Holdings Inc reports results for the quarter ended April 30Earnings Summary - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

EnGene Reports Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

enGene Holdings Inc. SEC 10-Q Report - TradingView

Jun 12, 2025
pulisher
Jun 11, 2025

enGene Holdings CMO Resignation Announced - MSN

Jun 11, 2025
pulisher
Jun 10, 2025

enGene Holdings Approves 2025 Employee Stock Purchase Plan - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

enGene Holdings Inc. adopts new employee stock plan - Investing.com

Jun 10, 2025
pulisher
Jun 09, 2025

ENGENE HOLDINGS Earnings Preview: Recent $ENGN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

enGene Holdings Expands with New Boston Lease - TipRanks

Jun 09, 2025
pulisher
Jun 07, 2025

(ENGN) On The My Stocks Page - news.stocktradersdaily.com

Jun 07, 2025
pulisher
Jun 05, 2025

enGene CMO Dr. Raj Pruthi to step down mid-June By Investing.com - Investing.com India

Jun 05, 2025
pulisher
Jun 04, 2025

EnGene Chief Medical Officer Raj Pruthi to Step Down - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

enGene CMO Dr. Raj Pruthi Resigns - citybiz

Jun 04, 2025
pulisher
Jun 04, 2025

enGene (ENGN) CMO Raj Pruthi Steps Down | ENGN Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

enGene CMO Dr. Raj Pruthi to step down mid-June - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

enGene Announces the Resignation of its Chief Medical Officer - Business Wire

Jun 04, 2025
pulisher
May 29, 2025

enGene to Present at the Jefferies Global Healthcare Conference - BioSpace

May 29, 2025
pulisher
May 29, 2025

enGene appoints new Chief Global Commercialization Officer By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

enGene Names Amy Pott as Chief Global Commercialization Officer - citybiz

May 28, 2025
pulisher
May 28, 2025

enGene appoints new Chief Global Commercialization Officer - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

enGene (ENGN) Appoints Amy Pott as New Chief Global Commercialization Officer | ENGN Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

EnGene Names Amy Pott As Chief Global Commercialization Officer - marketscreener.com

May 28, 2025
pulisher
May 27, 2025

When (ENGN) Moves Investors should Listen - news.stocktradersdaily.com

May 27, 2025
pulisher
May 27, 2025

Head-To-Head Review: enGene (NASDAQ:ENGN) vs. ImmunityBio (NASDAQ:IBRX) - Defense World

May 27, 2025
pulisher
May 17, 2025

Where are the Opportunities in (ENGN) - news.stocktradersdaily.com

May 17, 2025
pulisher
May 08, 2025

Is enGene Holdings (NASDAQ:ENGN) Using Too Much Debt? - simplywall.st

May 08, 2025
pulisher
May 06, 2025

(ENGN) Trading Signals - news.stocktradersdaily.com

May 06, 2025
pulisher
Apr 29, 2025

Citizens JMP reiterates Engene stock with $18 target By Investing.com - Investing.com Nigeria

Apr 29, 2025
pulisher
Apr 29, 2025

Citizens JMP reiterates Engene stock with $18 target - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

enGene to Participate in Upcoming Investor Conferences - Yahoo Finance

Apr 29, 2025
pulisher
Apr 29, 2025

enGene to Participate in Upcoming May 2025 Investor Conferences - BioSpace

Apr 29, 2025
pulisher
Apr 27, 2025

enGene Holdings Inc.'s (NASDAQ:ENGN) largest shareholders are private equity firms with 38% ownership, institutions own 35% - Yahoo Finance

Apr 27, 2025
pulisher
Apr 23, 2025

Is enGene Holdings Inc. (ENGN) the Best Canadian Penny Stock to Invest in Now? - Insider Monkey

Apr 23, 2025
pulisher
Apr 21, 2025

(ENGN) Technical Data - news.stocktradersdaily.com

Apr 21, 2025
pulisher
Apr 14, 2025

enGene (NASDAQ:ENGN) & Innate Pharma (OTCMKTS:IPHYF) Head-To-Head Survey - Defense World

Apr 14, 2025
pulisher
Apr 10, 2025

enGene Holdings Inc. (NASDAQ:ENGN) Receives Average Rating of “Buy” from Analysts - Defense World

Apr 10, 2025
pulisher
Apr 05, 2025

Trend Tracker for (ENGN) - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 04, 2025

Engene Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Apr 04, 2025
pulisher
Apr 04, 2025

enGene Expands Team with New Hires, Grants 144,650 Shares in Stock Options - Stock Titan

Apr 04, 2025

Finanzdaten der Engene Holdings Inc-Aktie (ENGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Engene Holdings Inc-Aktie (ENGN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Forbion Growth Opportunities F
10% Owner
Sep 30 '24
Buy
6.34
341,332
2,163,362
2,400,791
Forbion Growth Opportunities F
10% Owner
Sep 27 '24
Buy
5.97
41,639
248,699
2,059,459
Forbion Growth Opportunities F
10% Owner
Oct 01 '24
Buy
6.44
35,279
227,158
2,436,070
Forbion Growth Opportunities F
10% Owner
Oct 07 '24
Buy
6.55
11,844
77,531
2,469,833
Forbion Growth Opportunities F
10% Owner
Oct 02 '24
Buy
6.37
10,153
64,697
2,446,223
Forbion Growth Opportunities F
10% Owner
Oct 04 '24
Buy
6.54
5,997
39,242
2,457,989
Forbion Growth Opportunities F
10% Owner
Oct 03 '24
Buy
6.48
5,769
37,397
2,451,992
Forbion Growth Opportunities F
10% Owner
Oct 08 '24
Buy
6.60
800
5,278
2,470,633
Cooper Ronald Harold Wilfred
Chief Executive Officer
Sep 27 '24
Buy
5.70
10,000
57,000
10,000
$21.05
price up icon 1.77%
$35.85
price down icon 0.53%
$21.32
price down icon 0.15%
$99.46
price down icon 1.19%
$108.80
price up icon 2.21%
biotechnology ONC
$246.51
price up icon 1.76%
Kapitalisierung:     |  Volumen (24h):